Page last updated: 2024-08-24

aromasil and Malignant Mesothelioma

aromasil has been researched along with Malignant Mesothelioma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cordone, I; Cortese, G; Galati, R; Germoni, S; Masi, S; Morosetti, C; Nuvoli, B; Santoro, R	1

Other Studies

1 other study(ies) available for aromasil and Malignant Mesothelioma

Article	Year
Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease. Molecular cancer, 2014, Mar-21, Volume: 13 Topics: Androstadienes; Animals; Aromatase Inhibitors; Cell Proliferation; Cisplatin; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice; Xenograft Model Antitumor Assays	2014

Article

Year

Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease.

Molecular cancer, 2014, Mar-21, Volume: 13

Topics: Androstadienes; Animals; Aromatase Inhibitors; Cell Proliferation; Cisplatin; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice; Xenograft Model Antitumor Assays

2014